A Prospective, Multicenter Study to Evaluate the Clinical Performance of the GYNECARE PROSIMA* Pelvic Floor Repair System as a Procedure for Symptomatic POP-Q Stage II-III Pelvic Organ Prolapse
试验速览
- 阶段
- 不适用
- 入组人数
- 150
- 试验地点
- 30
- 主要终点
- Anatomical improvement according to POP-Q score.
研究概览
简要总结
The purpose of this study is to evaluate the safety and effectiveness of the GYNECARE PROSIMA* Pelvic Floor Repair System as a Device in Women with Symptomatic Pelvic Organ Prolapse.
详细描述
The GYNECARE PROSIMA* system is a new technique and now available in China. It provides a simplified unanchored mesh repair, making surgery much simpler to perform and reduces the risk of the specific complications that may occur when tunneling devices beyond the pelvic cavity.
In clinical practice, many women have symptomatic prolapse, which requires surgical correction. They are relatively young, and therefore care more about the long-term outcomes and quality of life after procedure. The purpose of this multicenter and prospective study is to evaluate the effectiveness and safety of the GYNECARE PROSIMA* system in the treatment of symptomatic POP-Q Stage II-III pelvic organ prolapse.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Candidates with symptomatic pelvic organ prolapse of ICS POP-Q Stage II or III, suitable for surgical repair. Vaginal hysterectomy and mid-urethral sling procedures for incontinence may be performed concurrently.
- •Age ≥ 18 years.
- •Agrees to participate in the study, including completion of all study-related procedures, evaluations and questionnaires, and documents this agreement by signing the Ethics Committee approved informed consent.
排除标准
- •Additional surgical intervention concurrent to the procedure (e.g. sacrocolpopexy, paravaginal repair, tubal sterilisation).
- •Previous repair of pelvic organ prolapse involving insertion of mesh.
- •Previous hysterectomy within 6 months of scheduled surgery.
- •Experimental drug or experimental medical device within 3 months prior to the planned procedure.
- •Active genital, urinary or systemic infection at the time of the surgical procedure. Surgery may be delayed in such subjects until the infection is cleared.
- •Coagulation disorder or on therapeutic anticoagulant therapy at the time of surgery.
- •History of chemotherapy or pelvic radiation therapy.
- •Systemic disease known to affect bladder or bowel function (e.g. Parkinson's disease, multiple sclerosis, spinal cord injury or trauma).
- •Current evaluation or treatment for chronic pelvic pain (e.g. interstitial cystitis, endometriosis, coccydynia, vulvodynia).
- •Nursing or pregnant or intends future pregnancy.
- •Chronic cough not well-controlled.
- •In the investigator's opinion, any medical condition or psychiatric illness that could potentially be life threatening or affect their ability to complete the study visits according to this protocol.
结局指标
主要结局
Anatomical improvement according to POP-Q score.
时间窗: 3 years
次要结局
- Pain score measured using Visual Analog Scale (VAS).(24 hours after surgery and postoperation visit at the 3-4 weeks.)
- Hospital data including operative time, estimated blood loss, length of stay, maximum temperature, time of voiding recovery.(At discharge, an expected average of 5 days after operation.)
- Discomfort of balloon removal, measured using VAS at time of removal.(24 hours after surgery.)
- Subject discomfort of VSD by VAS.(postoperation visit at 3-4 weeks.)
- Presence/absence of complications (composite score)(Up to 3 years.)
- Change from baseline in PFIQ-7 scores.(6 months, 12 months, 2 years and 3 years.)
- In subjects sexually active at baseline, assessment of sexual function using PISQ-12 (mean scores and change from baseline).(6 months, 12 months, 2 years and 3 years.)
- Subject global impression assessed on a 5 point Likert scale.(6 months, 12 months, 2 years and 3 years.)
